Clinical Trial

Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 22, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Historically, participation in medical studies is highly skewed towards particular demographic groups of people. This research will invite several participants to gather a wide range of information on clinical trial experiences for follicular lymphoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of follicular lymphoma. The data collected from this study will help improve future outcomes for all follicular lymphoma patients as well as those in under-represented demographic groups.
Trial Details
NCT Number NCT06049485
Lead Sponsor Power Life Sciences Inc.
Conditions Follicular Lymphoma
Enrollment 500 participants
Start Date 2024-10
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2023-09-22